54.675 USD
+17.6 (+47.49%)
Last: Feb 10, 2026, 03:53 PM
ChartMill assigns a Buy % Consensus number of 86% to NKTR. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 116.72. This target is 113.47% above the current price.
- NKTR was analyzed by 14 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about NKTR.
- In the previous month the buy percentage consensus was at a similar level.
- NKTR was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-02-10 | BTIG | Maintains | Buy -> Buy |
| 2026-02-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-01-29 | BTIG | Reiterate | Buy -> Buy |
| 2025-12-16 | BTIG | Maintains | Buy -> Buy |
| 2025-12-16 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-26 | Citigroup | Initiate | Buy |
| 2025-11-26 | Jefferies | Maintains | Buy -> Buy |
| 2025-09-23 | B. Riley Securities | Maintains | Buy -> Buy |
| 2025-09-19 | BTIG | Reiterate | Buy -> Buy |
| 2025-07-08 | B. Riley Securities | Maintains | Buy -> Buy |
| 2025-06-24 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-04-11 | Jefferies | Upgrade | Hold -> Buy |
| 2025-03-14 | Oppenheimer | Upgrade | Perform -> Outperform |
| 2025-03-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-08 | B. Riley Securities | Initiate | Buy |
| 2024-11-04 | Piper Sandler | Initiate | Overweight |
| 2024-03-06 | Jefferies | Maintains | Hold -> Hold |
| 2023-11-20 | JP Morgan | Reiterate | Underweight |
| 2023-11-09 | TD Cowen | Upgrade | Market Perform -> Outperform |
| 2023-08-07 | Mizuho | Reiterate | Neutral |
| 2023-05-10 | Jefferies | Upgrade | Underperform -> Hold |
| 2023-03-06 | Oppenheimer | Maintains | Perform |
| 2023-02-27 | Goldman Sachs | Maintains | Sell |
| 2023-02-24 | SVB Leerink | Maintains | Market Perform |
| 2023-02-24 | Jefferies | Downgrade | Hold -> Underperform |
| 2022-08-08 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2022-04-18 | Mizuho | Maintains | Neutral |
| 2022-04-18 | SVB Leerink | Maintains | Market Perform |
NEKTAR THERAPEUTICS / NKTR FAQ
Can you provide the average price target for NEKTAR THERAPEUTICS stock?
14 analysts have analysed NKTR and the average price target is 116.72 USD. This implies a price increase of 113.47% is expected in the next year compared to the current price of 54.675.
What is the consensus rating for NKTR stock?
The consensus rating for NEKTAR THERAPEUTICS (NKTR) is 85.7143 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover NEKTAR THERAPEUTICS (NKTR) stock?
The number of analysts covering NEKTAR THERAPEUTICS (NKTR) is 14.